Twelve-month clinical outcomes of 206 patients with chronic pulmonary aspergillosis
Fig 2
Change in St. George’s quality of life score at baseline, 6 months and 12 months for patients who were only on voriconazole (A) and itraconazole (B) for 12 months and for patients in whom voriconazole (C) or itraconazole (D) was discontinued.
Key: +, mean score: Middle bar, Median.